IPD Analytics publishes a semi-annual Drug Pipeline and Trend Impact Report. The report identifies new brands, generics, and biosimilars across over 40 therapeutic areas. Around the same time, our Executive Pharmacy Team hosts a series of pipeline webinars to discuss the drug launches that will have the greatest impact over the coming months. Listen to highlights from the most recent webinar and view a sample of our report including 2019 Key Approvals to Watch, Allergic Reactions, MS, and more.
DRUG PIPELINE & TREND IMPACT REPORT & WEBINAR SERIES
FEATURED SAMPLES
